Follow
Hanlin Zeng
Hanlin Zeng
Professor at Shanghai Jiao Tong University School of Medicine
Verified email at shsmu.edu.cn - Homepage
Title
Cited by
Cited by
Year
Feedback activation of leukemia inhibitory factor receptor limits response to histone deacetylase inhibitors in breast cancer
H Zeng, J Qu, N Jin, J Xu, C Lin, Y Chen, X Yang, X He, S Tang, X Lan, ...
Cancer cell 30 (3), 459-473, 2016
1312016
Bi-allelic loss of CDKN2A initiates melanoma invasion via BRN2 activation
H Zeng, A Jorapur, AH Shain, UE Lang, R Torres, Y Zhang, AS McNeal, ...
Cancer cell 34 (1), 56-68. e9, 2018
1262018
The genomic landscapes of individual melanocytes from human skin
J Tang, E Fewings, D Chang, H Zeng, S Liu, A Jorapur, RL Belote, ...
Nature 586 (7830), 600-605, 2020
1002020
Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer
N Jin, A Bi, X Lan, J Xu, X Wang, Y Liu, T Wang, S Tang, H Zeng, Z Chen, ...
Nature communications 10 (1), 2701, 2019
952019
Network modelling reveals the mechanism underlying colitis-associated colon cancer and identifies novel combinatorial anti-cancer targets
J Lu, H Zeng, Z Liang, L Chen, L Zhang, H Zhang, H Liu, H Jiang, B Shen, ...
Scientific reports 5 (1), 14739, 2015
592015
Mucosal melanoma: pathological evolution, pathway dependency and targeted therapy
Y Ma, R Xia, X Ma, RL Judson-Torres, H Zeng
Frontiers in Oncology 11, 702287, 2021
442021
Acetylation at lysine 71 inactivates superoxide dismutase 1 and sensitizes cancer cells to genotoxic agents
C Lin, H Zeng, J Lu, Z Xie, W Sun, C Luo, J Ding, S Yuan, M Geng, ...
Oncotarget 6 (24), 20578, 2015
242015
BRAFV600E induces reversible mitotic arrest in human melanocytes via microRNA-mediated suppression of AURKB
AS McNeal, RL Belote, H Zeng, M Urquijo, K Barker, R Torres, M Curtin, ...
Elife 10, e70385, 2021
232021
The evolution of melanoma–moving beyond binary models of genetic progression
H Zeng, RL Judson-Torres, AH Shain
Journal of Investigative Dermatology 140 (2), 291-297, 2020
132020
Hedgehog pathway orchestrates the interplay of histone modifications and tailors combination epigenetic therapies in breast cancer
X Wang, J Xu, Y Sun, S Cao, H Zeng, N Jin, M Shou, S Tang, Y Chen, ...
Acta Pharmaceutica Sinica B 13 (6), 2601-2612, 2023
52023
FADD amplification is associated with CD8+ T‐cell exclusion and malignant progression in HNSCC
Y Zheng, S Sheng, Y Ma, Y Chen, R Liu, W Zhang, L Zhang, Z Liu, Y He, ...
Oral Diseases, 2024
2024
Clinical management of a rare melanoma case arising from congenital melanocytic nevus
R Jiang, Y Wang, X Ma, X Xuanyuan, Y Zhang, B Jiang, W Zhang, H Zeng
Genes & Diseases 11 (3), 101005, 2024
2024
The single-cell landscape reveals unique tumor subsets and microenvironments associated with poor clinical outcomes in primary testicular diffuse large B-cell lymphoma
Z Bian, B Gu, G Shi, J Guo, D Li, H Zeng, B Jiang, D Min, H Su, Y Zhang
Genes & Diseases 11 (1), 80, 2024
2024
Clinical utilization of olaparib, a PARP inhibitor, in BRCA1-mutant metastatic acral melanoma
R Jiang, X Liang, Y Tao, R Xia, M Lei, B Jiang, RL Judson-Torres, ...
Genes & Diseases 10 (5), 1755, 2023
2023
SPRR1B+ keratinocytes prime oral mucosa for rapid wound healing via STAT3 activation
X Xuanyuan, L Zhang, Y Zheng, R Jiang, Y Ma, M Lei, H Xu, H Zeng
2023
The genomic landscapes ofindividual melanocytes from human skin (vol 586, pg 600, 2020)
J Tang, E Fewings, D Chang, H Zeng, S Liu, A Jorapur, RL Belote, ...
NATURE 590 (7844), 2021
2021
Publisher Correction: The genomic landscapes of individual melanocytes from human skin
J Tang, E Fewings, D Chang, H Zeng, S Liu, A Jorapur, RL Belote, ...
Nature 590 (7844), E20, 2021
2021
INVESTIGANDO EL CANCER DE PIEL: NUEVAS HERRAMIENTAS
J Tang, E Fewings, D Chang, H Zeng, S Liu
Los Ojos de la Ciencia 1 (11), 2020
2020
Bi-allelic loss of CDKN2A initiates melanoma invasion and metastasis via E2F1-BRN2 axis
H Zeng, A Jorapur, AH Shain, UE Lang, R Torres, Y Zhang, T Botton, J Lin, ...
Cancer Research 78 (13_Supplement), 5518-5518, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–19